HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabian Baltes Selected Research

Heparin (Liquaemin)

9/2017Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabian Baltes Research Topics

Disease

4Neoplasms (Cancer)
01/2020 - 09/2017
3Breast Neoplasms (Breast Cancer)
07/2020 - 12/2018
1Prostatic Neoplasms (Prostate Cancer)
05/2022
1Lung Neoplasms (Lung Cancer)
05/2022
1Neoplasm Metastasis (Metastasis)
07/2020
1Ovarian Neoplasms (Ovarian Cancer)
09/2017
1Thrombosis (Thrombus)
09/2017

Drug/Important Bio-Agent (IBA)

3Collagen Type I (Type I Collagen)IBA
07/2020 - 12/2018
3Cisplatin (Platino)FDA LinkGeneric
01/2020 - 09/2017
2Mitoxantrone (Novantrone)FDA LinkGeneric
01/2020 - 12/2018
1Androgen Antagonists (Antiandrogens)IBA
05/2022
1Proteolysis Targeting ChimeraIBA
05/2022
1Androgen Receptors (Androgen Receptor)IBA
05/2022
1Discoidin Domain Receptor 1IBA
07/2020
1Extracellular Matrix ProteinsIBA
07/2020
1Fibronectins (Fibronectin)IBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Irinotecan (Camptosar)FDA LinkGeneric
01/2020
1ProteomeIBA
12/2018
1Estrogens (Estrogen)FDA Link
12/2018
1Tinzaparin (Innohep)FDA Link
09/2017
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
09/2017
1Heparin (Liquaemin)FDA LinkGeneric
09/2017

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2020